EXODISCOVERY
LIVE

Serial Number

79360395

Owner

LabSpinner Inc.

Attorney

Sangwon Kim

Filing Date

Dec 5, 2022

Add to watchlist:

No watchlists yet
View on USPTO

EXODISCOVERY Trademark

Serial Number: 79360395 • Registration: 7416325

EXODISCOVERY is a trademark filed by LabSpinner Inc. on December 5, 2022. The trademark is classified under Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

LabSpinner Inc. (7 trademarks)

801-7ho, Gyeong-yeong-gwan,

Entity Type: 03

Trademark Details

Filing Date

December 5, 2022

Registration Date

June 18, 2024

Published for Opposition

April 2, 2024

Goods & Services

Medical analysis services relating to the treatment of persons; pathology services, namely, medical diagnosis and treatment of cancer; pathology services, namely, speech pathology therapy services; medical analysis for the diagnosis and treatment of persons; RNA or DNA medical analysis for cancer diagnosis and prognosis; medical analysis services for cancer diagnosis and prognosis; medical analysis services for the diagnosis of cancer; providing cancer screening services; providing information in the field of cancer prevention, screening, diagnosis and treatment; medical diagnostic services, namely, medical testing for diagnostic purposes and medical analysis for the diagnosis and treatment of persons; medical services in the field of oncology; medical testing services relating to the diagnosis and treatment of disease; performing diagnosis of diseases

Wholesale store services featuring reagents and media for medical and veterinary diagnostic purposes; wholesale store services featuring diagnostic preparations for medical and veterinary use; wholesale store services featuring chemical reagents for medical or veterinary purposes; wholesale store services featuring diagnostic reagents for medical or veterinary purposes; wholesale store services featuring diagnostic preparations for medical purposes; wholesale store services featuring diagnostic chemical reagents for medical use; wholesale store services featuring clinical medical reagents; wholesale store services featuring medical apparatus and instruments for RNA analysis other than for dental purposes; wholesale store services featuring test equipment for medical use; wholesale store services featuring body fluid analysis apparatus for medical purposes; wholesale store services featuring medical centrifuge other than for dental purposes; wholesale store services featuring medical apparatus and instruments in the fields of clinical diagnosis; wholesale store services featuring diagnostic apparatus and instruments for medical purposes; wholesale store services featuring blood analysis apparatus for diagnosis; wholesale store services featuring plasma separators; retail store services featuring diagnostic preparations for medical or veterinary purposes; retail store services featuring diagnostic preparations for medical purposes; retail store services featuring clinical medical reagents; retail store services featuring pharmaceutical preparations for diagnosis

Test equipment for medical use, namely, blood testing apparatus, eye testing apparatus, and multi-drug cups for drug use testing purposes; medical centrifuge other than for dental purposes in the nature of blood component separation apparatus for medical purposes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 14, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 25, 2024 FICS
FINAL DISPOSITION PROCESSED
Nov 25, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 18, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 18, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 18, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 10, 2024 OPNR
NOTIFICATION PROCESSED BY IB
Apr 15, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 2, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 27, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 27, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 28, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 27, 2024 TROA
REFUSAL PROCESSED BY IB
Nov 7, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 14, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 14, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 14, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 13, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 12, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 18, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 12, 2023 REPR